Publication stageIn Press Journal Pre-Proof
Funding sources: None
Conflicts of Interest: Disclosure of Interest: Dr. Lio reports research grants/funding from the National Eczema Association, Regeneron/Sanofi Genzyme, and AbbVie; is on the speaker's bureau for Regeneron/Sanofi Genzyme, Pfizer, and L'Oreal; reports consulting/advisory boards for UCB, Dermavant, Regeneron/Sanofi Genzyme, Dermira, Pfizer, LEO Pharmaceuticals, AbbVie, Kiniksa, Eli Lilly, Micreos (stock options), La Roche Posay/L'Oreal, Pierre-Fabre, Johnson & Johnson, Unilever, Menlo Therapeutics, Theraplex, IntraDerm, Exeltis, AOBiome, Realm Therapeutics, Franklin Bioscience/Altus Labs, Verrica, TopMD, Arbonne, Amyris, Burt's Bees. In addition, Dr. Lio is a Board member and Scientific Advisory Committee Member of the National Eczema Association. The other authors report no conflicts of interest.
IRB approval status: N/A; non-human subjects research
Clinicaltrials.gov (or equivalent) listing (if applicable): N/A
Reprint requests: Jeffrey Zhao